Supoat Charenkavanich

Statistics

Publications

Citations

H-Index

Active since

2007

Affiliations

Vanda Pharmaceuticals (United States)(Current)

Supoat Charenkavanich is an author at Vanda Pharmaceuticals (United States) specializing in medicine, insulin therapy, and heparin-protein interactions.

Publications per year

2007–2012

Publications

Randomized Comparison of Pramlintide or Mealtime Insulin Added to Basal Insulin Treatment for Patients With Type 2 Diabetes

Matthew C. Riddle, Richard Pencek, Supoat Charenkavanich et al. · Diabetes Care · 2009 · 66 citations · Full text

Medicine, Endocrinology, Internal Medicine +13

Heparin resistance in acute coronary syndromes

Jonathan D. Rich, John M. Maraganore, Edward Young et al. · Journal of Thrombosis and Thrombolysis · 2007 · 16 citations

Medicine, Cardiology, Pharmacotherapy +14

Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow‐fill‐seal device in adults: a randomized, active‐controlled study<b>*</b>

Eric Sheldon, Robert Jeanfreau, Joseph Sliman et al. · Influenza and Other Respiratory Viruses · 2012 · 15 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

1–3 of 3